Physician

Christopher C Johnson, MD

According to 2025 Medicare claims, Christopher Johnson, MD (NPI: 1215952247) practices cardiology in the Bremerton-Silverdale-Port Orchard, WA market, with the plurality of this provider's patient population coming from Kitsap, WA. This provider's primary affiliated billing organization is FRANCISCAN MEDICAL GROUP (NPI: 1366539421; TIN: 911939739) and primary practice location at 98383-7663. Johnson is affiliated with the CommonSpirit ACO I (ACO ID: A2164), Jefferson Accountable Care, LLC (ACO ID: A5275), and PSW ACO (ACO ID: A5323), participating under the MSSP model.

Johnson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,938 traditional Medicare patients, billed 4,893 HCPCS/CPT codes, and received $264,709 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 4,278 prescription claims across 662 beneficiaries totaling $1,279,582 in drug costs, led by Vyndamax (Tafamidis). 2015 DME data shows 11 claims. Open Payments data shows 2 records totaling $45. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $164,173 to $264,709. Similarly, Part D prescription costs have moved sharply higher in recent years, from $88,778 to $1,279,582. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,873	3,223	$164,173
2016	2,159	4,422	$193,005
2017	2,102	4,429	$213,748
2018	2,555	4,985	$235,130
2019	2,694	6,194	$345,206
2020	1,706	3,558	$206,667
2021	2,077	4,637	$275,698
2022	2,049	5,702	$329,262
2023	2,441	7,159	$366,973
2024	1,938	4,893	$264,709

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	291	1,578	$88,778
2016	263	1,574	$108,867
2017	226	1,693	$105,214
2018	267	1,575	$124,016
2019	332	2,272	$216,839
2020	372	2,632	$276,464
2021	425	2,968	$418,325
2022	433	3,115	$604,560
2023	475	3,314	$827,695
2024	662	4,278	$1,279,582

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$98
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	473	473	$128
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	643	864	$88
93016	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician	217	218	$16
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	230	241	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	551	719	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	12	360	$311,198
Eliquis	Apixaban	236	14,115	$269,141
Xarelto	Rivaroxaban	206	12,782	$239,613
Entresto	Sacubitril/Valsartan	123	7,650	$169,930
Jardiance	Empagliflozin	103	7,230	$132,404

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$45	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher C. Johnson, MD?

Tedicare shows public-source Medicare data for Christopher C. Johnson, MD (NPI 1215952247), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher C. Johnson, MD have ACO affiliation data?

Christopher C. Johnson, MD is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164), Jefferson Accountable Care, LLC (MSSP, ACO ID A5275), and PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Christopher C. Johnson, MD?

Christopher C. Johnson, MD is linked to FRANCISCAN MEDICAL GROUP (billing NPI 1366539421) in the available physician profile data.

Does Christopher C. Johnson, MD have Open Payments data?

Christopher C. Johnson, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.